companydata.dkcompanydata.dk

BACH BOLIGCENTER ApS: Financial statements 2023

CVR: 12024584

Source: annual report 2023, Danish Business Authority

01/05/2022 – 30/04/2023

BACH BOLIGCENTER ApS (CVR 12024584) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -15,335 and a net result of DKK -200,720 compared with DKK -153,237 the year before. Equity in the 2023 report amounted to DKK 424,365. The solvency ratio was 95.4%. The company had 1 employee in the financial year.

Gross Profit
DKK -15,335
Profit/Loss
DKK -200,720
Equity
DKK 424,365
Total Assets
DKK 444,644
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--15K-201K424K1
2022--14K-153K682K1
2021--13K-9K892K1
2020--14K-166K956K0
2019--17K12K1.2M1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

About BACH BOLIGCENTER ApS

BACH BOLIGCENTER ApS is a Danish company of the type Anpartsselskab based in Hammel, founded in 1988. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named EMBRYODAN ApS. The management consists of Geo Koch. The company is owned by Geo Koch. The company has 1 employee (2023). In 2026, the company reported a gross profit of DKK -12,635 and a net result of DKK 3,958 compared with DKK -35,885 the year before. Equity in the 2026 report amounted to DKK 243,122.

Source: annual report 2026, Danish Business Authority